Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12626)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 8, 2016 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Pediatrics
ISSN
2219-2808
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Castellanos D, Gralnik LM. Synthetic cannabinoids 2015: An update for pediatricians in clinical practice. World J Clin Pediatr 2016; 5(1): 16-24 [PMID: 26862498 DOI: 10.5409/wjcp.v5.i1.16] |
|---|---|
| URL: | https://www.wjgnet.com/2219-2808/full/v5/i1/16.htm |
| Number | Citing Articles |
| 1 |
Koby Cohen, Yaniv Mama, Paola Rosca, Albert Pinhasov, Aviv Weinstein. Chronic Use of Synthetic Cannabinoids Is Associated With Impairment in Working Memory and Mental Flexibility. Frontiers in Psychiatry 2020; 11 doi: 10.3389/fpsyt.2020.00602
|
| 2 |
Franziska Gaunitz, Sabrina Lehmann, Andreas Thomas, Mario Thevis, Markus A. Rothschild, Katja Mercer-Chalmers-Bender. Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication. International Journal of Legal Medicine 2018; 132(6): 1645 doi: 10.1007/s00414-018-1911-8
|
| 3 |
Amandine Scocard, Amine Benyamina, Sarah Coscas, Laurent Karila. Cannabinoïdes de synthèse : une nouvelle matrice des addictions. La Presse Médicale 2017; 46(1): 11 doi: 10.1016/j.lpm.2016.11.014
|
| 4 |
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott, Jim McCambridge. The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 2017; 5(4): 1 doi: 10.3310/phr05040
|
| 5 |
Jeremy T. Goldbach, Ethan H. Mereish, Claire Burgess. Sexual Orientation Disparities in the Use of Emerging Drugs. Substance Use & Misuse 2017; 52(2): 265 doi: 10.1080/10826084.2016.1223691
|
| 6 |
David Hakimian, Orr Tomer, Nurith Hiller, Samuel N. Heyman, Sarah Israel. Fatal Mesenteric Ischemia Induced by Synthetic Cannabinoids: A Case Report and Literature Review. Case Reports in Emergency Medicine 2017; 2017: 1 doi: 10.1155/2017/6964078
|
| 7 |
Wafaa M. Abdelmoneim, Marwa H. Bakr, Nagwa M. Ghandour, Marwa Kh. Mohammed, Mohamed Fawzy, Abdelrahman G. Ramadan, Nora Z. Abdellah. Cytotoxicity associated with acute and chronic administration of synthetic cannabinoids “Strox” in the brain, liver, heart, and testes of male albino rats: histological and immunohistochemical study. Egyptian Journal of Forensic Sciences 2023; 13(1) doi: 10.1186/s41935-023-00331-8
|
| 8 |
Laurent Karila, Amine Benyamina. Cannabis Use Disorders. 2019; : 169 doi: 10.1007/978-3-319-90365-1_16
|
| 9 |
Andreas K. Breitbarth, Jody Morgan, Alison L. Jones. E-cigarettes—An unintended illicit drug delivery system. Drug and Alcohol Dependence 2018; 192: 98 doi: 10.1016/j.drugalcdep.2018.07.031
|
| 10 |
Ismail Altintop, Cigdem Karakukcu. The Chameleon-Like Properties of Psychoactive Drugs: Examinations with HR LC-MS/MS Technology of Patients Presenting at the Emergency Department Following the Use of Synthetic Cannabinoids: A Case Series and Literature Review. Behavioral Sciences 2018; 8(10): 88 doi: 10.3390/bs8100088
|
| 11 |
Stephanie Campos, Ellen Benoit, Eloise Dunlap. Risk management strategies of synthetic cannabis users. Drugs and Alcohol Today 2019; 19(4): 270 doi: 10.1108/DAT-04-2019-0012
|
| 12 |
Grażyna Kucharska, Magdalena Filipska, Piotr Adamczyk, Katarzyna Lipiec, Dagmara Roszkowska-Bjanid, Elżbieta Trembecka-Dubel, Maria Szczepańska. Ostre uszkodzenie nerek w przebiegu zatrucia metamfetaminą. Pediatria Polska 2016; 91(5): 496 doi: 10.1016/j.pepo.2016.06.007
|
| 13 |
Samuel D. Banister, Mitchell Longworth, Richard Kevin, Shivani Sachdev, Marina Santiago, Jordyn Stuart, James B. C. Mack, Michelle Glass, Iain S. McGregor, Mark Connor, Michael Kassiou. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues. ACS Chemical Neuroscience 2016; 7(9): 1241 doi: 10.1021/acschemneuro.6b00137
|
| 14 |
Martin H. Bluth, Matthew R. Pincus. Narcotic Analgesics and Common Drugs of Abuse. Clinics in Laboratory Medicine 2016; 36(4): 603 doi: 10.1016/j.cll.2016.07.013
|
| 15 |
Yu-Jang Su, Tse-Hao Chen, Wei-Hsiang Liao, Kuo-Song Chang, Yen-Chun Lai. Clinical characteristics in new psychoactive substance users: A single center study. Medicine 2023; 102(25): e34084 doi: 10.1097/MD.0000000000034084
|
| 16 |
Koby Cohen, Aviv Weinstein. The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review. Brain Sciences 2018; 8(3): 40 doi: 10.3390/brainsci8030040
|
| 17 |
Efrat Kelmer, Jakob A. Shimshoni, Yael Merbl, Ofer Kolski, Sigal Klainbart. Use of gas chromatography–mass spectrometry for definitive diagnosis of synthetic cannabinoid toxicity in a dog. Journal of Veterinary Emergency and Critical Care 2019; 29(5): 573 doi: 10.1111/vec.12872
|
| 18 |
Paweł Szpot, Karolina Nowak, Olga Wachełko, Kaja Tusiewicz, Agnieszka Chłopaś-Konowałek, Marcin Zawadzki. Methyl (S)-2-(1–7 (5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (5F-MDMB-PICA) intoxication in a child with identification of two new metabolites (ultra-high-performance liquid chromatography–tandem mass spectrometry). Forensic Toxicology 2023; 41(1): 47 doi: 10.1007/s11419-022-00629-7
|
| 19 |
Genevieve Lafaye, Laurent Karila, Lisa Blecha, Amine Benyamina. Cannabis, cannabinoids, and health. Dialogues in Clinical Neuroscience 2017; 19(3): 309 doi: 10.31887/DCNS.2017.19.3/glafaye
|
| 20 |
Ersin Göl, İsmet Çok. Assessment of types of synthetic cannabinoids in narcotic cases assessed by the Council of Forensic Medicine between 2011–2015, Ankara, Turkey. Forensic Science International 2017; 280: 124 doi: 10.1016/j.forsciint.2017.09.017
|
| 21 |
R Le Boisselier, J Alexandre, V Lelong‐Boulouard, D Debruyne. Focus on cannabinoids and synthetic cannabinoids. Clinical Pharmacology & Therapeutics 2017; 101(2): 220 doi: 10.1002/cpt.563
|
| 22 |
Nozomi Asaoka, Hiroyuki Kawai, Naoya Nishitani, Haruko Kinoshita, Norihiro Shibui, Kazuki Nagayasu, Hisashi Shirakawa, Shuji Kaneko. A new designer drug 5F-ADB activates midbrain dopaminergic neurons but not serotonergic neurons. The Journal of Toxicological Sciences 2016; 41(6): 813 doi: 10.2131/jts.41.813
|
| 23 |
EM Guler, MY Bektay, AG Akyildiz, BH Sisman, FV Izzettin, A Kocyigit. Investigation of DNA damage, oxidative stress, and inflammation in synthetic cannabinoid users. Human & Experimental Toxicology 2020; 39(11): 1454 doi: 10.1177/0960327120930057
|
| 24 |
Anas A Abu Jad, Anvesh Ravanavena, Chetna Ravindra, Emmanuelar O Igweonu-Nwakile, Safina Ali, Salomi Paul, Shreyas Yakkali, Sneha Teresa Selvin, Sonu Thomas, Viktoriya Bikeyeva, Ahmed Abdullah, Aleksandra Radivojevic, Prachi Balani. Adverse Effects of Cannabinoids and Tobacco Consumption on the Cardiovascular System: A Systematic Review. Cureus 2022; doi: 10.7759/cureus.29208
|
| 25 |
Yuri P. Springer, Roy Gerona, Erich Scheunemann, Sarah L. Shafer, Thomas Lin, Samuel D. Banister, Michael P. Cooper, Louisa J. Castrodale, Michael Levy, Jay C. Butler, Joseph B. McLaughlin. Increase in Adverse Reactions Associated with Use of Synthetic Cannabinoids — Anchorage, Alaska, 2015–2016. MMWR. Morbidity and Mortality Weekly Report 2016; 65(40): 1108 doi: 10.15585/mmwr.mm6540a4
|
| 26 |
Maren Hermanns-Clausen, Dieter Müller, Josephine Kithinji, Verena Angerer, Florian Franz, Florian Eyer, Hartmud Neurath, Gesine Liebetrau, Volker Auwärter. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA. Clinical Toxicology 2018; 56(6): 404 doi: 10.1080/15563650.2017.1393082
|
| 27 |
Eric Rowley, David Benson, Aaron Tiffee, Adam Hockensmith, Henry Zeng, Glenn N. Jones, Mandi W. Musso. Clinical and financial implications of emergency department visits for synthetic marijuana. The American Journal of Emergency Medicine 2017; 35(10): 1506 doi: 10.1016/j.ajem.2017.04.044
|
| 28 |
Brandon J. Warrick, Anita Paula Tataru, Roy Gerona. New Psychoactive Substances in Pediatric Patients. Pediatric Clinics of North America 2017; 64(6): 1223 doi: 10.1016/j.pcl.2017.08.003
|
| 29 |
Mona N. Bahouth, Peggy Kraus, Kathryn Dane, Manuela Plazas Montana, William Tsao, Burton Tabaac, Jagar Jasem, Holly Schmidlin, Evan Einstein, Michael B. Streiff, Satish Shanbhag. Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides. Medicine 2019; 98(36): e17015 doi: 10.1097/MD.0000000000017015
|
| 30 |
Satyajit Mohite, Hanjing Wu, Shiva Sharma, Luca Lavagnino, Cristian P. Zeni, Terrence T. Currie, Jair C. Soares, Teresa A. Pigott. Higher Prevalence of Metabolic Syndrome in Child-adolescent Patients with Bipolar Disorder. Clinical Psychopharmacology and Neuroscience 2020; 18(2): 279 doi: 10.9758/cpn.2020.18.2.279
|
| 31 |
Rosheen Mary Grady, Vladimir Belostotsky, Kristen M Hallett, Christina N Grant. A 15-year-old boy with acute onset abdominal pain and hypertension. Paediatrics & Child Health 2017; 22(6): 301 doi: 10.1093/pch/pxx089
|
| 32 |
Kevin Ball. What does Dame Carol Black’s review of drug and alcohol misuse services mean for probation services?. European Journal of Probation 2022; 14(3): 282 doi: 10.1177/20662203221147107
|
| 33 |
Heba Mohamed Aboubakr, Somaya Hassan Shaheen, Asmaa Mohammad Moawad, Marwa Abdelgwad, Noha El-Sayed Ibrahim, Nadia Makhlouf ElKady, Fatma Mohamed Hassan. Oxidative stress response, cell proliferation, and apoptosis in patients with synthetic cannabinoid use disorder. Toxicologie Analytique et Clinique 2023; 35(4): 311 doi: 10.1016/j.toxac.2023.06.004
|
| 34 |
Aaron J. Roberto, Aileen Lorenzo, Kevin J. Li, Jonathan Young, Abhishek Mohan, Subhash Pinnaka, Kyle A. B. Lapidus. First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone. Case Reports in Psychiatry 2016; 2016: 1 doi: 10.1155/2016/7257489
|
| 35 |
Jessica V. Rivera, Emily Green Vance, William F. Rushton, Justin K. Arnold. Novel Psychoactive Substances and Trends of Abuse. Critical Care Nursing Quarterly 2017; 40(4): 374 doi: 10.1097/CNQ.0000000000000174
|
| 36 |
Timothy W Lefever, Julie A Marusich, Brian F Thomas, Daniel G Barrus, Nicholas C Peiper, Richard C Kevin, Jenny L Wiley. Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in Mice. Substance Abuse: Research and Treatment 2017; 11: 117822181770173 doi: 10.1177/1178221817701739
|
| 37 |
Koby Cohen, Shiri Rosenzweig, Paola Rosca, Albert Pinhasov, Abraham Weizman, Aviv Weinstein. Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users. Frontiers in Psychiatry 2020; 11 doi: 10.3389/fpsyt.2020.00355
|
| 38 |
Natalie Thurtle, Rachelle Abouchedid, John R. H. Archer, James Ho, Takahiro Yamamoto, Paul I. Dargan, David M. Wood. Prevalence of Use of Electronic Nicotine Delivery Systems (ENDS) to Vape Recreational Drugs by Club Patrons in South London. Journal of Medical Toxicology 2017; 13(1): 61 doi: 10.1007/s13181-016-0583-3
|
| 39 |
Gary Sweet, Sara Kim, Samuel Martin, Nicole B. Washington, Nancy Brahm. Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians. Mental Health Clinician 2017; 7(4): 156 doi: 10.9740/mhc.2017.07.156
|
| 40 |
Carmen C.W Lim, Janni K.Y Leung, Jason P. Connor, Wayne D. Hall, Coral Gartner, Brandon H.C Cheng, Roman W. Scheurer, Tianze Sun, Gary C.K Chan. Availability of substances for use in personal vaporisers on three online cryptomarkets. Drug and Alcohol Dependence 2020; 217: 108254 doi: 10.1016/j.drugalcdep.2020.108254
|
| 41 |
Franziska Gaunitz, Hilke Andresen-Streichert. Analytical findings in a non-fatal intoxication with the synthetic cannabinoid 5F-ADB (5F-MDMB-PINACA): a case report. International Journal of Legal Medicine 2022; 136(2): 577 doi: 10.1007/s00414-021-02717-6
|
| 42 |
Kirsten Elin Smith, Amanda M. Bunting, Michele Staton, Robert Walker, Sara Shalash, Erin Winston, Kevin Pangburn. Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013–2015. Journal of Psychoactive Drugs 2017; 49(5): 436 doi: 10.1080/02791072.2017.1361560
|
| 43 |
Brandon Bills, Nicholas Manicke. Using Sesame Seed Oil to Preserve and Preconcentrate Cannabinoids for Paper Spray Mass Spectrometry. Journal of the American Society for Mass Spectrometry 2020; 31(3): 675 doi: 10.1021/jasms.9b00113
|
| 44 |
Miriam Schneider, Chris Maria Friemel, Rupert von Keller, Kristina Adorjan, Udo Bonnet, Alkomiet Hasan, Derik Hermann, Joseph Kambeitz, Dagmar Koethe, Ludwig Kraus, F. Markus Leweke, Beat Lutz, Liane Paul, Oliver Pogarell, Ulrich Preuss, Michael Schäfer, Sophia Schmieder, Roland Simon, Martin Storr, Eva Hoch. Cannabis: Potenzial und Risiko. 2019; : 65 doi: 10.1007/978-3-662-57291-7_3
|
| 45 |
David D Aguilar, Andrea Giuffrida, Daniel J Lodge. Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia Susceptibility. International Journal of Neuropsychopharmacology 2018; 21(4): 393 doi: 10.1093/ijnp/pyy003
|
| 46 |
Léa Hamel-Senecal, Valentin Philippe, Basile Chrétien, Mathilde Lechevrel, Reynald Le Boisselier. Vapoter les drogues, un usage à risques. Therapies 2018; 73(6): 581 doi: 10.1016/j.therap.2018.09.030
|
| 47 |
Brandon J. Bills, Jeffrey Kinkade, Greta Ren, Nicholas E. Manicke. The impacts of paper properties on matrix effects during paper spray mass spectrometry analysis of prescription drugs, fentanyl and synthetic cannabinoids. Forensic Chemistry 2018; 11: 15 doi: 10.1016/j.forc.2018.08.002
|